GSK and Pfizer RSV Vaccines for Pregnant Women Increased Risk of Preterm Births — GSK Ended Its Trials, but FDA Approved Pfizer Shots GSK and Pfizer RSV Vaccines for Pregnant Women Increased Risk of Preterm Births — GSK Ended Its Trials, but FDA Approved Pfizer Shots March 17, 2024 GSK stopped developing a vaccine for pregnant women to protect newborns against syncytial virus (RSV) after identifying an increased risk of preterm births. Pfizer won…
GSK and Pfizer RSV Vaccines for Pregnant Women Increased Risk of Preterm Births — GSK Ended Its Trials, but FDA Approved Pfizer Shots
GSK stopped developing a vaccine for pregnant women to protect newborns against syncytial virus (RSV) after identifying an increased risk of preterm births. Pfizer won…